iStock Rating

F
Details...
Enter Symbol click to research

Watson Pharmaceuticals, Inc. (NYSE: WPI)

Sector: Medical

Current Price : $85.73

52 Week Low
$55.89
52 Week High
$90.85
 

WATSON PHA(NYSE:WPI)
Watson Pharmaceuticals, Inc. is a pharmaceutical company primarily engagedin the development, production, marketing and distribution of both branded and off-patent pharmaceutical products. The company''s branded pharmaceutical business operates primarily in three specialty areas: Dermatology, Women''s Health and General Products. The company''s products include therapeutic and preventive agents generally sold by prescription or over-the-counter for the treatment of human diseases and disorders.
# Employees: 6686
Address: MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY,PARSIPPANY,NJ,USA
Phone: 9092701400
Fax: 951-493-5300
Website: www.watson.com
Email: investor.relations@watson.com
Sector: Medical
Industry: MED-GENERIC DRG
Executive Officers
Andrew L. Turner (Chairman)
Paul M. Bisaro (President and Chief Executive Officer)
R. Todd Joyce (Exec.V.P.;C.F.O.)
Christopher W. Bodine (Director)
Michael J. Fedida (Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2012
Next Earnings Date(Expected): 2/12/2013
Mean EPS (Next Qtr): $1.88
Mean EPS (Year): $8.21
Mean Estimate(Long Term): $13.81
P/E Ratio(Based on EPS estimate): 10.420
Number of Estimates: 20
Shares Performance
Period wpi Compare to S&P
YTD -0.60 % -5.70 %
4 Weeks -5.23 % -7.93 %
12 Weeks -1.62 % -6.46 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1373164
Shares Outstanding: 127M
Market Cap: $10.92B
52 Week High: $90.85
52 Week Low: $55.89
P/E Ratio: 13.830
PEG Ratio: 0.750
Split: On 10/30/1997 wpi split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -4.93 %
EPS Growth in Last Year: 23.85 %
Sales Growth in Last Quarter: -5.17 %
Sales Growth in Last Quarter: 18.82 %
Financials
Qtr Book Value: $2.96
Cash Flow/Share: $10.34
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.